MonoNessa Dosage
Generic name: norgestimate and ethinyl estradiol
Dosage form: tablets
This dosage information does not include all the information needed to use MonoNessa safely and effectively. See full prescribing information for MonoNessa.
The information at Drugs.com is not a substitute for medical advice. ALWAYS consult your doctor or pharmacist.
Oral Contraception
To achieve maximum contraceptive effectiveness, MonoNessa® must be taken exactly as directed and at intervals not exceeding 24 hours. The possibility of ovulation and conception prior to initiation of medication should be considered. MonoNessa® is available in a blister card with a tablet dispenser which is preset for a Sunday Start. Day 1 Start is also provided.
Sunday Start
When taking MonoNessa®, the first blue "active" tablet should be taken on the first Sunday after menstruation begins. If the period begins on Sunday, the first tablet should be taken that day. Take one active tablet daily for 21 days followed by one dark green inactive tablet daily for 7 days. After 28 tablets have been taken, a new course is started the next day (Sunday). For the first cycle of a Sunday Start regimen, another method of contraception should be used until after the first 7 consecutive days of administration.
If the patient misses one (1) active tablet in Weeks 1, 2, or 3, the tablet should be taken as soon as she remembers. If the patient misses two (2) active tablets in Week 1 or Week 2, the patient should take two (2) tablets the day she remembers and two (2) tablets the next day; and then continue taking one (1) tablet a day until she finishes the pack. The patient should be instructed to use a back-up method of birth control such as a condom or spermicide if she has sex in the seven (7) days after missing pills. If the patient misses two (2) active tablets in the third week or misses three (3) or more active tablets in a row, the patient should continue taking one tablet every day until Sunday. On Sunday the patient should throw out the rest of the pack and start a new pack that same day. The patient should be instructed to use a back-up method of birth control if she has sex in the seven (7) days after missing pills.
Complete instructions to facilitate patient counseling on proper pill usage may be found in the Detailed Patient Labeling ("How to Take the Pill" section).
Day 1 Start
The dosage of MonoNessa® for the initial cycle of therapy is one blue "active" tablet administered daily from the 1st day through the 21st day of the menstrual cycle, counting the first day of menstrual flow as "Day 1" followed by one dark green inactive tablet daily for 7 days. Tablets are taken without interruption for 28 days. After 28 tablets have been taken, a new course is started the next day.
If the patient misses one (1) active tablet in Weeks 1, 2, or 3, the tablet should be taken as soon as she remembers. If the patient misses two (2) active tablets in Week 1 or Week 2, the patient should take two (2) tablets the day she remembers and two (2) tablets the next day; and then continue taking one (1) tablet a day until she finishes the pack. The patient should be instructed to use a back-up method of birth control such as a condom or spermicide if she has sex in the seven (7) days after missing pills. If the patient misses two (2) active tablets in the third week or misses three (3) or more active tablets in a row, the patient should throw out the rest of the pack and start a new pack that same day. The patient should be instructed to use a back-up method of birth control if she has sex in the seven (7) days after missing pills.
Complete instructions to facilitate patient counseling on proper pill usage may be found in the Detailed Patient Labeling ("How to Take the Pill" section).
The use of MonoNessa® for contraception may be initiated 4 weeks postpartum in women who elect not to breastfeed. When the tablets are administered during the postpartum period, the increased risk of thromboembolic disease associated with the postpartum period must be considered. (See CONTRAINDICATIONS and WARNINGS concerning thromboembolic disease. See also PRECAUTIONS: Nursing Mothers.) The possibility of ovulation and conception prior to initiation of medication should be considered.
(See Discussion of Dose-Related Risk of Vascular Disease from Oral Contraceptives.)
See also...
- Mononessa Side Effects
- Mononessa Drug Interactions
- Ethinyl Estradiol/Norgestimate dosage information
- Ortho Cyclen (ethinyl estradiol/norgestimate) consumer information
- Ortho Tri-Cyclen (norgestimate and ethinyl estradiol) tablets dosage information
- Ortho Tri-Cyclen (ethinyl estradiol/norgestimate) consumer information
- Ortho Tri-Cyclen Lo (norgestimate and ethinyl estradiol) tablets dosage information
- Previfem (norgestimate and ethinyl estradiol) tablets dosage information
- Sprintec (norgestimate and ethinyl estradiol) tablets dosage information
- Tri-Lo-Sprintec (norgestimate and ethinyl estradiol) tablets dosage information
- Tri-Previfem (norgestimate and ethinyl estradiol) tablets dosage information
- Tri-Sprintec (norgestimate and ethinyl estradiol) tablets dosage information
- TriNessa (norgestimate and ethinyl estradiol) tablet dosage information
- TriNessa Lo (norgestimate and ethinyl estradiol) tablets dosage information


